# A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension

> **NCT02676947** · PHASE2 · COMPLETED · sponsor: **Papworth Hospital NHS Foundation Trust** · enrollment: 29 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Tocilizumab

## Key facts

- **NCT ID:** NCT02676947
- **Lead sponsor:** Papworth Hospital NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-02-18
- **Final completion:** 2018-02-18
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2018-04-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02676947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02676947, "A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02676947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*